Tags

Type your tag names separated by a space and hit enter

Treatment resistant impetigo herpetiformis treated with infliximab.
Dermatol Ther. 2019 03; 32(2):e12839.DT

Abstract

Impetigo herpetiformis is a rare disease of pregnancy with the onset being in the second half of pregnancy and resolution after delivery. It is associated with a high rate of perinatal mortality and fetal abnormalities. Clinical and histological features of the disease are consistent with pustuler psoriasis. We reported a case of 25-year-old female gravida 1 para 0, who responded poorly to consecutive treatments with systemic steroids, cyclosporine, intravenous immunoglobulin, and acitretin. Good response was obtained with adding infliximab to the treatment.

Authors+Show Affiliations

Department of Dermatology and Venereology, School of Medicine, Gaziosmanpasa University, Tokat, Turkey.Department of Dermatology and Venereology, School of Medicine, Gaziosmanpasa University, Tokat, Turkey.Department of Dermatology and Venereology, School of Medicine, Gaziosmanpasa University, Tokat, Turkey.Department of Pathology, School of Medicine, Gaziosmanpasa University, Tokat, Turkey.

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

30693621

Citation

Ogrum, Atiye, et al. "Treatment Resistant Impetigo Herpetiformis Treated With Infliximab." Dermatologic Therapy, vol. 32, no. 2, 2019, pp. e12839.
Ogrum A, Takci Z, Seckin HY, et al. Treatment resistant impetigo herpetiformis treated with infliximab. Dermatol Ther. 2019;32(2):e12839.
Ogrum, A., Takci, Z., Seckin, H. Y., & Cetin, E. (2019). Treatment resistant impetigo herpetiformis treated with infliximab. Dermatologic Therapy, 32(2), e12839. https://doi.org/10.1111/dth.12839
Ogrum A, et al. Treatment Resistant Impetigo Herpetiformis Treated With Infliximab. Dermatol Ther. 2019;32(2):e12839. PubMed PMID: 30693621.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Treatment resistant impetigo herpetiformis treated with infliximab. AU - Ogrum,Atiye, AU - Takci,Zennure, AU - Seckin,Havva Yildiz, AU - Cetin,Elif, Y1 - 2019/02/12/ PY - 2018/11/28/received PY - 2019/01/24/accepted PY - 2019/1/30/pubmed PY - 2019/11/14/medline PY - 2019/1/30/entrez KW - impetigo herpetiformis KW - pregnancy KW - pustular psoriasis KW - treatment resistant SP - e12839 EP - e12839 JF - Dermatologic therapy JO - Dermatol Ther VL - 32 IS - 2 N2 - Impetigo herpetiformis is a rare disease of pregnancy with the onset being in the second half of pregnancy and resolution after delivery. It is associated with a high rate of perinatal mortality and fetal abnormalities. Clinical and histological features of the disease are consistent with pustuler psoriasis. We reported a case of 25-year-old female gravida 1 para 0, who responded poorly to consecutive treatments with systemic steroids, cyclosporine, intravenous immunoglobulin, and acitretin. Good response was obtained with adding infliximab to the treatment. SN - 1529-8019 UR - https://www.unboundmedicine.com/medline/citation/30693621/Treatment_resistant_impetigo_herpetiformis_treated_with_infliximab_ DB - PRIME DP - Unbound Medicine ER -